Literature DB >> 2170602

Tissue response to composite ceramic hydroxyapatite/demineralized bone implants.

G Y Pettis1, L B Kaban, J Glowacki.   

Abstract

This study evaluated the tissue reactions to two materials: ceramic hydroxyapatite (CHA), and a composite material of demineralized bone powder (DBP) and CHA (ratio of 4:1) in a collagen vehicle. The materials were tested in a subcutaneous pocket, a mandibular onlay, and in a calvarial onlay model. Specimens were evaluated histologically at 7, 10, 14, and 21 days postimplantation. Ceramic hydroxyapatite, implanted subcutaneously, elicited a fibrous response with minimal inflammation, but did not induce bone formation. In specimens of subcutaneously implanted composite material, induced bone was evident in association with the DBP. In CHA onlay specimens, there was a small amount of reactive bone extending from the host bone into the implant. In composite onlays, bone filled the entire body of the implant. The results of this study indicate that CHA particles were not osteoinductive in heterotopic sites and that osteoconductive ingrowth was minimal in onlays. Bone was induced by DBP even when mixed with CHA particles and implanted in subcutaneous and intraosseous sites. It was concluded that composite implants may provide a means of combining the osteoinductive properties of DBP with the bulk and structural support of osteoconductive CHA particles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170602     DOI: 10.1016/0278-2391(90)90291-9

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

2.  Tissue response and the cytoconduction ability to collagen/hydroxyapatite heterotopic implantation.

Authors:  Z Xia; T Zhu; J Du; L Wang
Journal:  J Tongji Med Univ       Date:  1997

3.  The fate of porous hydroxyapatite granules used in facial skeletal augmentation.

Authors:  Bryan C Mendelson; Steve R Jacobson; Alain M Lavoipierre; Richard J Huggins
Journal:  Aesthetic Plast Surg       Date:  2010-02-26       Impact factor: 2.326

Review 4.  Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 5.  Biomimetic approaches with smart interfaces for bone regeneration.

Authors:  G S Sailaja; P Ramesh; Sajith Vellappally; Sukumaran Anil; H K Varma
Journal:  J Biomed Sci       Date:  2016-11-05       Impact factor: 8.410

Review 6.  Injectable agents: present and future.

Authors:  Deborah J Lightner; Nancy B Itano; Susan D Sweat; Kristin L Chrouser; Felecia Fick
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

Review 7.  Use of calcium hydroxylapatite (Radiesse) for facial augmentation.

Authors:  Patricio F Jacovella
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.